Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 52
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

How oceanographic conditions affect the growth, diet, and survival of juvenile rockfish

Rockfish are important fishery species on the U.S. West coast. Many rockfish species were overfished in the...

Monitoring Bird Migration on Monomoy Island

With the cooperation of US Fish and Wildlife and Monomoy National Wildlife Refuge, Monomoy Bird Observatory...

Backer Badge Funded